| 1.3 |
4.0 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 1.1 |
4.5 |
GO:0010903 |
negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 1.0 |
2.9 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.9 |
2.7 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.9 |
2.7 |
GO:0009107 |
lipoate biosynthetic process(GO:0009107) |
| 0.9 |
0.9 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.7 |
2.2 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.7 |
5.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.7 |
4.9 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.7 |
2.0 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.6 |
1.9 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.6 |
0.6 |
GO:0043173 |
purine nucleotide salvage(GO:0032261) nucleotide salvage(GO:0043173) |
| 0.6 |
1.7 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.6 |
2.3 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.6 |
1.7 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
| 0.6 |
1.1 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.6 |
0.6 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 |
2.2 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.5 |
3.2 |
GO:0000089 |
mitotic metaphase(GO:0000089) |
| 0.5 |
4.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.5 |
3.1 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.5 |
0.5 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.5 |
1.5 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) regulation of phospholipid catabolic process(GO:0060696) positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.5 |
12.3 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.5 |
1.5 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.5 |
2.0 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.5 |
2.0 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.5 |
1.4 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.5 |
1.8 |
GO:0033602 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) |
| 0.5 |
1.4 |
GO:0070445 |
Fc receptor mediated stimulatory signaling pathway(GO:0002431) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.5 |
1.4 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 0.5 |
0.5 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 0.4 |
1.3 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.4 |
1.3 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.4 |
1.8 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
| 0.4 |
1.7 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.4 |
0.8 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
| 0.4 |
2.9 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.4 |
1.2 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.4 |
1.2 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.4 |
1.2 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.4 |
2.7 |
GO:0045780 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.4 |
2.3 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 |
1.5 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.4 |
0.8 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.4 |
1.5 |
GO:1904035 |
endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
| 0.4 |
0.7 |
GO:0001866 |
natural killer cell proliferation(GO:0001787) NK T cell proliferation(GO:0001866) NK T cell activation(GO:0051132) |
| 0.3 |
0.7 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
1.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
1.0 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 |
0.6 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.3 |
1.9 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.3 |
2.2 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.3 |
1.9 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.3 |
0.3 |
GO:0061081 |
positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.3 |
0.9 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.3 |
1.2 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.3 |
0.9 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.3 |
1.2 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
1.8 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.3 |
2.7 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.3 |
2.4 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 |
0.9 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.3 |
0.9 |
GO:0061198 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 0.3 |
0.6 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.3 |
0.3 |
GO:0021754 |
facial nucleus development(GO:0021754) |
| 0.3 |
0.3 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.3 |
0.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 |
2.6 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.3 |
2.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.3 |
0.8 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
1.1 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 0.3 |
0.8 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.3 |
0.8 |
GO:2000105 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) positive regulation of DNA-dependent DNA replication(GO:2000105) |
| 0.3 |
1.4 |
GO:0045767 |
obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.3 |
0.5 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.3 |
1.1 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.3 |
2.6 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.3 |
0.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 |
0.8 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.3 |
5.9 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.3 |
3.1 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.3 |
2.3 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.3 |
2.8 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.2 |
0.7 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.2 |
0.2 |
GO:0043467 |
regulation of generation of precursor metabolites and energy(GO:0043467) |
| 0.2 |
0.2 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.2 |
0.5 |
GO:0070340 |
detection of bacterial lipoprotein(GO:0042494) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.2 |
2.0 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
1.0 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.2 |
1.2 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 |
1.0 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.2 |
1.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
0.2 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.2 |
2.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.2 |
0.7 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 |
0.7 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.2 |
0.2 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 |
2.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
0.2 |
GO:0032651 |
regulation of interleukin-1 beta production(GO:0032651) |
| 0.2 |
1.2 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.2 |
1.1 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.2 |
0.7 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.2 |
1.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
0.7 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 |
0.4 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 |
0.8 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.2 |
2.1 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.2 |
0.8 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
1.4 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.2 |
2.6 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
0.2 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.2 |
0.8 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.2 |
0.2 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.2 |
0.6 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
1.0 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 |
0.6 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.2 |
0.4 |
GO:0030578 |
nuclear body organization(GO:0030575) PML body organization(GO:0030578) |
| 0.2 |
2.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.2 |
2.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.2 |
1.7 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.2 |
1.3 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.2 |
0.6 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.2 |
0.4 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
0.9 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.2 |
0.4 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.2 |
0.6 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.2 |
0.7 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 |
1.9 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.2 |
1.3 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.2 |
0.7 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
0.6 |
GO:0042253 |
granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.2 |
0.7 |
GO:0009211 |
pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) |
| 0.2 |
0.4 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.2 |
3.6 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.2 |
2.9 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.2 |
0.4 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.2 |
0.7 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
0.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
0.5 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.2 |
0.9 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.2 |
0.7 |
GO:0090305 |
nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
| 0.2 |
0.5 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.2 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
0.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.2 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
1.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 |
2.0 |
GO:0032814 |
regulation of natural killer cell activation(GO:0032814) |
| 0.2 |
1.7 |
GO:0032615 |
interleukin-12 production(GO:0032615) |
| 0.2 |
1.0 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.2 |
2.0 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.8 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 0.2 |
0.5 |
GO:0071104 |
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.2 |
1.0 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 |
5.3 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.2 |
0.7 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.2 |
0.5 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.2 |
5.4 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
0.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
0.8 |
GO:0006991 |
response to sterol depletion(GO:0006991) |
| 0.2 |
0.2 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 |
0.6 |
GO:0048799 |
organ maturation(GO:0048799) bone maturation(GO:0070977) |
| 0.2 |
0.5 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) spindle midzone assembly(GO:0051255) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.2 |
0.6 |
GO:0006288 |
base-excision repair, DNA ligation(GO:0006288) |
| 0.2 |
0.6 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
0.5 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.2 |
0.6 |
GO:0002360 |
T cell lineage commitment(GO:0002360) |
| 0.2 |
0.3 |
GO:0043523 |
regulation of neuron apoptotic process(GO:0043523) regulation of neuron death(GO:1901214) |
| 0.2 |
0.2 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.2 |
3.8 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.2 |
0.5 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.2 |
0.6 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.2 |
0.8 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
0.5 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.4 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.1 |
0.3 |
GO:0010572 |
regulation of cellular extravasation(GO:0002691) positive regulation of platelet activation(GO:0010572) |
| 0.1 |
0.4 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.1 |
GO:0018105 |
peptidyl-serine phosphorylation(GO:0018105) |
| 0.1 |
0.4 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 |
0.1 |
GO:0042637 |
catagen(GO:0042637) |
| 0.1 |
0.4 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.9 |
GO:0007063 |
regulation of sister chromatid cohesion(GO:0007063) |
| 0.1 |
0.9 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.7 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
1.6 |
GO:0014911 |
positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 |
2.3 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.1 |
1.3 |
GO:0032354 |
response to follicle-stimulating hormone(GO:0032354) |
| 0.1 |
0.9 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.1 |
0.4 |
GO:0043247 |
telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 |
1.1 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.6 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.7 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.4 |
GO:0006929 |
substrate-dependent cell migration(GO:0006929) |
| 0.1 |
0.6 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.1 |
0.4 |
GO:0072216 |
positive regulation of metanephros development(GO:0072216) positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.1 |
3.4 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.1 |
0.1 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.1 |
0.5 |
GO:0021759 |
globus pallidus development(GO:0021759) menarche(GO:0042696) |
| 0.1 |
0.4 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.1 |
0.5 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) |
| 0.1 |
2.8 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.1 |
0.4 |
GO:0019827 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.1 |
0.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
0.8 |
GO:0016064 |
immunoglobulin mediated immune response(GO:0016064) |
| 0.1 |
0.9 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 |
0.3 |
GO:0043049 |
otic placode formation(GO:0043049) |
| 0.1 |
0.5 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) |
| 0.1 |
0.3 |
GO:0048251 |
elastic fiber assembly(GO:0048251) extracellular matrix assembly(GO:0085029) |
| 0.1 |
1.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.1 |
GO:0072177 |
mesonephric duct development(GO:0072177) |
| 0.1 |
0.1 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.1 |
0.3 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.1 |
0.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.3 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.1 |
0.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
2.0 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.4 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.1 |
0.5 |
GO:1902622 |
regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
| 0.1 |
0.7 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.6 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
1.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.7 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
0.5 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.7 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.8 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.5 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
| 0.1 |
0.7 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.1 |
0.5 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.1 |
0.4 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.1 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.7 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.9 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.1 |
GO:0003160 |
endocardium development(GO:0003157) endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 0.1 |
1.2 |
GO:0002886 |
regulation of myeloid leukocyte mediated immunity(GO:0002886) |
| 0.1 |
0.6 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
1.4 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.7 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.1 |
3.0 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.2 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.1 |
1.0 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.1 |
0.5 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.1 |
0.3 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.3 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.1 |
0.3 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.1 |
0.4 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 |
0.8 |
GO:0072079 |
nephron tubule formation(GO:0072079) |
| 0.1 |
0.8 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.4 |
GO:0072383 |
mitotic centrosome separation(GO:0007100) plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.1 |
0.7 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
1.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
1.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.2 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 |
0.3 |
GO:0048865 |
stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.1 |
0.4 |
GO:0042981 |
regulation of cell death(GO:0010941) regulation of apoptotic process(GO:0042981) regulation of programmed cell death(GO:0043067) |
| 0.1 |
0.2 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.5 |
GO:0045953 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
0.1 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
5.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
2.0 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.1 |
0.1 |
GO:0042345 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.1 |
0.2 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
1.8 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.1 |
0.5 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.4 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.1 |
1.8 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.4 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.4 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
1.7 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.1 |
0.1 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 |
8.6 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
0.4 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.1 |
0.8 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
0.4 |
GO:0043065 |
positive regulation of apoptotic process(GO:0043065) |
| 0.1 |
0.6 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.4 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.1 |
0.2 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
| 0.1 |
0.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
1.6 |
GO:0045069 |
regulation of viral genome replication(GO:0045069) |
| 0.1 |
0.6 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.5 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.1 |
0.8 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
1.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.5 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.3 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
| 0.1 |
0.1 |
GO:0042508 |
tyrosine phosphorylation of Stat1 protein(GO:0042508) |
| 0.1 |
0.1 |
GO:0019530 |
taurine metabolic process(GO:0019530) |
| 0.1 |
0.3 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
1.3 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.3 |
GO:0019918 |
peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 |
0.5 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.1 |
0.5 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.6 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.4 |
GO:0045299 |
otolith mineralization(GO:0045299) |
| 0.1 |
0.4 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.4 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 |
0.2 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.2 |
GO:0032885 |
regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) regulation of polysaccharide metabolic process(GO:0032881) regulation of polysaccharide biosynthetic process(GO:0032885) positive regulation of glycogen biosynthetic process(GO:0045725) regulation of glycogen metabolic process(GO:0070873) positive regulation of glycogen metabolic process(GO:0070875) |
| 0.1 |
0.3 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.1 |
0.1 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
1.7 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.1 |
GO:0061024 |
membrane organization(GO:0061024) |
| 0.1 |
0.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
0.1 |
GO:0071502 |
cellular response to temperature stimulus(GO:0071502) |
| 0.1 |
1.2 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.1 |
0.6 |
GO:0033235 |
regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.2 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
1.6 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 |
0.3 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.6 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 |
0.6 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.1 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
1.6 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.1 |
0.6 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.1 |
0.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.3 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.6 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
0.4 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.2 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) histone H3-K27 methylation(GO:0070734) |
| 0.1 |
0.5 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
2.4 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 0.1 |
0.5 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.1 |
0.4 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
1.6 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.1 |
3.9 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 |
0.9 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.2 |
GO:1901798 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.4 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
1.9 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
0.4 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
0.4 |
GO:0007440 |
foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 0.1 |
0.3 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.1 |
1.3 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
0.2 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
0.5 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.3 |
GO:0009450 |
gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.1 |
0.6 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.4 |
GO:0051099 |
positive regulation of binding(GO:0051099) |
| 0.1 |
1.5 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.1 |
0.5 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.5 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.1 |
0.2 |
GO:2000078 |
regulation of type B pancreatic cell development(GO:2000074) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.1 |
1.6 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.1 |
1.1 |
GO:1902603 |
carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.1 |
0.1 |
GO:0032647 |
interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
| 0.1 |
0.2 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
0.3 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.1 |
0.2 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.1 |
0.2 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.1 |
0.2 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.6 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.1 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
0.4 |
GO:0072073 |
kidney epithelium development(GO:0072073) |
| 0.1 |
0.2 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.1 |
0.1 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.1 |
0.3 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
| 0.1 |
2.0 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
1.6 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 |
0.5 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.1 |
0.5 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 |
0.5 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.4 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
0.2 |
GO:0045005 |
DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 |
0.6 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
0.7 |
GO:1903078 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 |
0.1 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.8 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.1 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.1 |
0.2 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.3 |
GO:0042816 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
| 0.1 |
0.1 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.1 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.6 |
GO:0010921 |
regulation of phosphatase activity(GO:0010921) |
| 0.1 |
0.6 |
GO:1901663 |
quinone biosynthetic process(GO:1901663) |
| 0.1 |
0.6 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.6 |
GO:0051966 |
regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 |
0.6 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.1 |
0.4 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.2 |
GO:1904396 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.1 |
0.3 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.8 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.4 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.2 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
1.2 |
GO:0002639 |
positive regulation of immunoglobulin production(GO:0002639) |
| 0.1 |
1.0 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
| 0.1 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
2.3 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.3 |
GO:0033363 |
secretory granule organization(GO:0033363) |
| 0.1 |
0.3 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
6.4 |
GO:0050851 |
antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.1 |
0.2 |
GO:0034126 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) positive regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034126) |
| 0.1 |
0.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.5 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.1 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.1 |
1.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.2 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.3 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.2 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.1 |
1.6 |
GO:0043487 |
regulation of RNA stability(GO:0043487) |
| 0.1 |
0.6 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.2 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.6 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 |
0.3 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.8 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.1 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.1 |
0.5 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.1 |
0.6 |
GO:0046827 |
regulation of protein export from nucleus(GO:0046825) positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.7 |
GO:0034375 |
high-density lipoprotein particle remodeling(GO:0034375) |
| 0.1 |
0.3 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.4 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.2 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.1 |
0.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.3 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
| 0.1 |
0.7 |
GO:0032608 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.1 |
GO:0035054 |
embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.1 |
0.3 |
GO:0030878 |
thyroid gland development(GO:0030878) |
| 0.1 |
2.2 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
0.2 |
GO:0051661 |
maintenance of organelle location(GO:0051657) maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.4 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
| 0.1 |
0.1 |
GO:0051938 |
L-amino acid import(GO:0043092) L-glutamate import(GO:0051938) |
| 0.1 |
0.3 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.1 |
1.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.1 |
0.2 |
GO:0016575 |
protein deacetylation(GO:0006476) histone deacetylation(GO:0016575) protein deacylation(GO:0035601) macromolecule deacylation(GO:0098732) |
| 0.1 |
1.1 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.1 |
0.7 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
1.3 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.1 |
1.7 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.1 |
2.0 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.1 |
0.1 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.1 |
0.2 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
3.2 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.1 |
0.4 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.1 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.1 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.3 |
GO:0032527 |
retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 |
3.3 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.0 |
1.4 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.5 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.3 |
GO:0043524 |
negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
| 0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
1.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.0 |
GO:0042754 |
negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) negative regulation of circadian rhythm(GO:0042754) |
| 0.0 |
0.4 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.2 |
GO:0051497 |
negative regulation of actin filament bundle assembly(GO:0032232) negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 |
1.3 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.6 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.2 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.1 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
0.5 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.0 |
0.8 |
GO:0050812 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.0 |
0.5 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.7 |
GO:0033574 |
response to testosterone(GO:0033574) |
| 0.0 |
0.2 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.0 |
0.0 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.0 |
1.0 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
1.3 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.0 |
0.1 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) neurotransmitter receptor metabolic process(GO:0045213) |
| 0.0 |
0.2 |
GO:0071593 |
T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
| 0.0 |
2.8 |
GO:0010827 |
regulation of glucose transport(GO:0010827) |
| 0.0 |
0.1 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.0 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.5 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.1 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
| 0.0 |
0.5 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.0 |
0.3 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.2 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.1 |
GO:0072202 |
cell differentiation involved in metanephros development(GO:0072202) |
| 0.0 |
0.0 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.4 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.1 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.1 |
GO:0019079 |
viral genome replication(GO:0019079) |
| 0.0 |
0.2 |
GO:0071545 |
polyol catabolic process(GO:0046174) inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.1 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.0 |
0.1 |
GO:0007271 |
synaptic transmission, cholinergic(GO:0007271) |
| 0.0 |
0.2 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.0 |
0.2 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.9 |
GO:0001906 |
cell killing(GO:0001906) |
| 0.0 |
0.3 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
1.9 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.6 |
GO:0050709 |
negative regulation of protein secretion(GO:0050709) |
| 0.0 |
0.4 |
GO:0050704 |
regulation of interleukin-1 secretion(GO:0050704) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.0 |
0.0 |
GO:0060534 |
trachea cartilage development(GO:0060534) |
| 0.0 |
0.1 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.4 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.0 |
0.1 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.1 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.0 |
0.4 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.0 |
0.6 |
GO:0000090 |
mitotic anaphase(GO:0000090) |
| 0.0 |
0.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.0 |
0.2 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.1 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.7 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.0 |
0.0 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) mesenchymal cell proliferation(GO:0010463) |
| 0.0 |
0.6 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
1.2 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.0 |
2.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.2 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.0 |
0.1 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.4 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.2 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.1 |
GO:0001552 |
ovarian follicle atresia(GO:0001552) |
| 0.0 |
0.4 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.1 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.7 |
GO:0007389 |
pattern specification process(GO:0007389) |
| 0.0 |
0.1 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.0 |
0.2 |
GO:0001701 |
in utero embryonic development(GO:0001701) |
| 0.0 |
0.3 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.2 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.2 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.0 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.2 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.0 |
0.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.1 |
GO:0050983 |
spermidine catabolic process(GO:0046203) deoxyhypusine biosynthetic process from spermidine(GO:0050983) |
| 0.0 |
0.4 |
GO:0006582 |
melanin metabolic process(GO:0006582) |
| 0.0 |
0.1 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 |
0.2 |
GO:0009451 |
RNA modification(GO:0009451) |
| 0.0 |
0.7 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.0 |
0.1 |
GO:0001507 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0071428 |
rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.0 |
0.3 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.0 |
0.6 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.6 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.0 |
0.3 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.2 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.2 |
GO:0016571 |
histone methylation(GO:0016571) |
| 0.0 |
1.1 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.2 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
0.0 |
GO:0042748 |
circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.0 |
0.2 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.0 |
0.4 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.8 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.2 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.0 |
0.6 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
| 0.0 |
0.2 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 |
0.5 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.3 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.0 |
4.2 |
GO:0050776 |
regulation of immune response(GO:0050776) |
| 0.0 |
0.8 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 |
0.3 |
GO:0070588 |
calcium ion transmembrane transport(GO:0070588) |
| 0.0 |
0.8 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.3 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.0 |
0.0 |
GO:0009221 |
pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 0.0 |
0.1 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 |
0.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 |
0.2 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.0 |
0.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 |
0.1 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
4.4 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 |
0.2 |
GO:0021533 |
cell differentiation in hindbrain(GO:0021533) |
| 0.0 |
0.4 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.0 |
0.1 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
| 0.0 |
0.1 |
GO:0021940 |
regulation of cerebellar granule cell precursor proliferation(GO:0021936) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.0 |
0.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.0 |
0.1 |
GO:0034383 |
low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 |
0.2 |
GO:0007128 |
meiotic prophase I(GO:0007128) |
| 0.0 |
0.4 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.1 |
GO:0043584 |
nose development(GO:0043584) |
| 0.0 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.0 |
0.4 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 |
0.5 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
1.0 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 |
0.1 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) |
| 0.0 |
0.1 |
GO:0051051 |
negative regulation of transport(GO:0051051) |
| 0.0 |
0.4 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.0 |
0.1 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.0 |
0.2 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 |
0.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.2 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:0034723 |
DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 |
0.1 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
0.1 |
GO:0015851 |
nucleobase transport(GO:0015851) |
| 0.0 |
0.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.0 |
0.2 |
GO:0002026 |
regulation of the force of heart contraction(GO:0002026) |
| 0.0 |
0.1 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.1 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.4 |
GO:0009308 |
amine metabolic process(GO:0009308) |
| 0.0 |
0.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.1 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 |
0.2 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.0 |
0.1 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.0 |
0.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.0 |
0.1 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.2 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 |
0.1 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.0 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) purine deoxyribonucleotide catabolic process(GO:0009155) deoxyribonucleoside triphosphate catabolic process(GO:0009204) purine deoxyribonucleoside triphosphate metabolic process(GO:0009215) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
| 0.0 |
0.0 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
| 0.0 |
0.2 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.1 |
GO:0018101 |
protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
| 0.0 |
0.4 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.0 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.0 |
0.3 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.0 |
0.1 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
2.8 |
GO:0045333 |
cellular respiration(GO:0045333) |
| 0.0 |
0.4 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.0 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) positive regulation of receptor internalization(GO:0002092) |
| 0.0 |
0.2 |
GO:0016070 |
RNA metabolic process(GO:0016070) |
| 0.0 |
0.3 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.0 |
GO:0010001 |
glial cell differentiation(GO:0010001) |
| 0.0 |
0.0 |
GO:0000239 |
pachytene(GO:0000239) |
| 0.0 |
0.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.1 |
GO:0048048 |
embryonic eye morphogenesis(GO:0048048) |
| 0.0 |
0.2 |
GO:0071479 |
cellular response to ionizing radiation(GO:0071479) |
| 0.0 |
0.1 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 |
0.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.1 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.0 |
0.8 |
GO:0000236 |
mitotic prometaphase(GO:0000236) |
| 0.0 |
0.2 |
GO:0075713 |
establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.0 |
0.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
2.3 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.3 |
GO:0001502 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.0 |
0.1 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.0 |
0.1 |
GO:0034067 |
protein targeting to Golgi(GO:0000042) protein localization to Golgi apparatus(GO:0034067) establishment of protein localization to Golgi(GO:0072600) |
| 0.0 |
0.0 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.0 |
0.0 |
GO:1902600 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 |
0.1 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.0 |
0.0 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
0.2 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.2 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.0 |
GO:0046886 |
positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
0.2 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.0 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.0 |
0.0 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.1 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 |
1.4 |
GO:0042254 |
ribosome biogenesis(GO:0042254) |
| 0.0 |
0.5 |
GO:0050796 |
regulation of insulin secretion(GO:0050796) |
| 0.0 |
0.0 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.1 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.0 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.3 |
GO:0033045 |
regulation of sister chromatid segregation(GO:0033045) |
| 0.0 |
0.0 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
| 0.0 |
0.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.0 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.0 |
0.0 |
GO:0034367 |
macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
| 0.0 |
0.1 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.0 |
0.1 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.0 |
0.1 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.0 |
0.1 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.0 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.0 |
0.0 |
GO:0070228 |
regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.0 |
0.6 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.8 |
GO:0006323 |
DNA packaging(GO:0006323) |
| 0.0 |
0.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.2 |
GO:0042098 |
T cell proliferation(GO:0042098) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.0 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 |
0.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.0 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.0 |
0.0 |
GO:0032227 |
regulation of synaptic transmission, dopaminergic(GO:0032225) negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.0 |
0.3 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.2 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.0 |
0.1 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.6 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.0 |
0.3 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.1 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.1 |
GO:0045727 |
positive regulation of cellular amide metabolic process(GO:0034250) positive regulation of translation(GO:0045727) |
| 0.0 |
0.0 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.0 |
0.3 |
GO:0035337 |
fatty-acyl-CoA metabolic process(GO:0035337) fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 |
0.4 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.0 |
GO:0090208 |
positive regulation of triglyceride metabolic process(GO:0090208) |
| 0.0 |
0.0 |
GO:0071456 |
cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
| 0.0 |
0.3 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.0 |
0.1 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
